Lein Applied Diagnostics: Developing non-invasive glucose monitoring technology.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Lein Applied Diagnostics: Developing non-invasive glucose monitoring technology.
Released on: November 01, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Dan Daly, CEO of Lein Applied Diagnostics talks about the company's dynamic technology.
  • Summary
  • Transcript
  • Participants
  • Company
Dan Daly, CEO of Lein Applied Diagnostics talks about the company's dynamic technology. Based around a scanning confocal system, Lein are developing novel, non-contact, optical sensing technologies with applications in high resolution optical metrology, non-invasive glucose monitoring, and pharmacokinetics.
Dan Daly, CEO of Lein Applied Diagnostics talks about the company's dynamic technology. Based around a scanning confocal system, Lein are developing novel, non-contact, optical sensing technologies with applications in high resolution optical metrology, non-invasive glucose monitoring, and pharmacokinetics.
Dan Daly
Lein Applied Diagnostics
Lein Applied Diagnostics
Lein Applied Diagnostics is a dynamic technology company pioneering measurement devices and solutions for the healthcare and industrial markets. Its core technology is based around a scanning confocal system that can make highly precise, non-contact dimensional and structural measurements of organic and man made materials. Key to its success is the use of novel optical, electronic and mechanical technologies. Together these enable Lein to fulfil customers’ high accuracy measurement requirements in both a compact and cost effective manner.